Accumulated evidence revealed that the protective effects of Nrf2 against SLE in some cellular and mouse models [17, 41] and the activation of the NLRP3 inflammasome and NF-κB pathway contributed to the development of LN [3, 2, 17, 42, 43]. This evidence concerns the gene NLRP3 and lobular neoplasia.